Quarterly report [Sections 13 or 15(d)]

Condensed Statements of Operations (Unaudited)

v3.25.2
Condensed Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Revenues
Operating Expenses:        
Research and development 363,000 1,784,000 1,462,000 2,561,000
Selling, general and administrative (including $4,000 and $120,000 from stock compensation for the three months ended June 30, 2025 and 2024, respectively, and $7,000 and $222,000 for the six months ended June 30, 2025 and 2024, respectively) 1,150,000 2,122,000 1,983,000 4,436,000
Loss from Operations (1,513,000) (3,906,000) (3,445,000) (6,997,000)
Other Income (Expense)        
Interest income 38,000 105,000 70,000 247,000
Change in fair value of warrant liability (114,000) 117,000 12,000 775,000
Gain on settlement of vendor payable 998,000
Other income 156,000 (27,000) 156,000
Unrealized gain on short-term investments 1,000 (1,000)
Total Other Income (Expense), Net 80,000 196,000 1,236,000 1,021,000
Net Loss (1,433,000) (3,710,000) (2,209,000) (5,976,000)
Dividends on preferred stock (85,000) (85,000)
Net Loss attributable to common stockholders’ $ (1,518,000) $ (3,710,000) $ (2,294,000) $ (5,976,000)
Net Loss Per Share - Basic $ (0.55) $ (2.17) $ (0.90) $ (3.86)
Net Loss Per Share - Diluted $ (0.55) $ (2.17) $ (0.90) $ (3.86)
Weighted average common shares outstanding - basic 2,771,765 1,711,955 2,559,604 1,546,294
Weighted average common shares outstanding - diluted 2,771,765 1,711,955 2,559,604 1,546,294